Importantly, the TGF-β/HDAC7 signaling pathway can repress oxidative phosphorylation in RCC [53], and the administration of TGF-β inhibitor restores the expression of TCA cycle enzymes and inhibits tumor progression in the orthotopic RCC model. Here, TGFB1 is linked to renal cell carcinoma.